Francis Willard Sarena's Net Worth
$13.2 Million
Who is Francis Willard Sarena?
Francis Willard Sarena has an estimated net worth of $13.2 Million. This is based on reported shares across multiple companies, which include FACET BIOTECH CORP, Apexigen, Inc., PDL BIOPHARMA, INC., and FIVE PRIME THERAPEUTICS, INC..
SEC CIK
Francis Willard Sarena's CIK is 0001423786
Past Insider Trading and Trends
2016 was Francis Willard Sarena's most active year for acquiring shares with 15 total transactions. Francis Willard Sarena's most active month to acquire stocks was the month of December. 2016 was Francis Willard Sarena's most active year for disposing of shares, totalling 24 transactions. Francis Willard Sarena's most active month to dispose stocks was the month of March. 2016 saw Francis Willard Sarena paying a total of $575,668.02 for 188,364 shares, this is the most they've acquired in one year. In 2021 Francis Willard Sarena cashed out on 612,905 shares for a total of $6,725,428.58, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
FACET BIOTECH CORP No price found
VP Gen Counsel & SecyFrancis Willard Sarena used to own units in Common Stock but no longer holds any shares there. From 2008 to 2010 Francis Willard Sarena acquired a total of 25,289 shares in FACET BIOTECH CORP, Francis also disposed a total of 27,808 shares of FACET BIOTECH CORP equalling to $728,299.80.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -16.28K |
$27.00 | -$439,479.00 |
0
|
Apr 21
| |||
Form 4
| -37.83% | -9.88K |
$27.00 | -$266,625.00 | 16.23K |
Apr 20
| |||
Form 4
| -4.47% | -1.18K |
$16.34 | -$19,313.88 | 25.28K |
Sep 14
| |||
Form 4
| +37.74% | 6.92K |
—
|
—
| 25.27K |
Aug 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 2
| |||
Form 4
| -2.52% | -474.00 |
$6.08 | -$2,881.92 | 18.34K |
Jan 31
| |||
Form 4
| +4,072.28% | 18.37K |
—
|
—
| 18.82K |
Jan 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Apexigen, Inc. No price found
President and COOFrancis Willard Sarena used to own units in Common Stock but no longer holds any shares there. In the year 2022 Francis Willard Sarena acquired a total of 190,000 shares in Apexigen, Inc., Francis also disposed a total of 190,000 shares of Apexigen, Inc. equalling to $31,012.57.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -155.42K |
$0.39 |
—
|
0
|
Aug 23
| |||
Form 4
| -4.26% | -6.92K |
$0.49 | -$3,396.94 | 155.42K |
Jun 15
| |||
Form 4
| +390.68% | 129.25K |
$0.40 | -$8,299.20 | 162.34K |
May 23
| |||
Form 4
| -17.29% | -6.92K |
$1.06 | -$7,330.96 | 33.08K |
Dec 15
| |||
Form 4
|
∞
| 40K |
—
|
—
| 40K |
Oct 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PDL BIOPHARMA, INC. No price found
VP/Gen Counsel/SecyFrancis Willard Sarena owns 5,756 units of Common Stock. In the year 2008 Francis Willard Sarena filed a total of 3 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -8.52% | -536.00 |
$10.84 | -$5,810.24 | 5.76K |
Sep 15
| |||
Form 4
| +46.60% | 2K |
—
|
—
| 6.29K |
Jan 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
FIVE PRIME THERAPEUTICS, INC. No price found
Chief Strategy OfficerFrancis Willard Sarena used to own units in Common Stock but no longer holds any shares there. From 2013 to 2021 Francis Willard Sarena acquired a total of 355,496 shares in FIVE PRIME THERAPEUTICS, INC. at a cost of $595,811.46, Francis also disposed a total of 365,734 shares of FIVE PRIME THERAPEUTICS, INC. equalling to $13,074,766.18.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -99.36% | -123.93K |
$38.00 | -$6,530,414.00 | 795 |
Apr 1 - Apr 16
| |||
Form 4
| -0.93% | -1.16K |
$22.23 | -$25,742.34 | 123.43K |
Feb 26
| |||
Form 4
| -5.14% | -6.75K |
$25.07 | -$169,272.24 | 124.59K |
Feb 24 - Feb 25
| |||
Form 4
| +8.98% | 10.42K |
$16.14 | -$186,949.62 | 126.43K |
Dec 11
| |||
Form 4
| +10.47% | 11K |
$18.00 | -$198,018.00 | 116.01K |
Nov 11
| |||
Form 4
| +34.32% | 26.83K |
$4.85 | -$15,371.13 | 105.01K |
Feb 24 - Feb 26
| |||
Form 4
| -4.95% | -4.07K |
$5.13 | -$20,879.10 | 78.18K |
Feb 5
| |||
Form 4
| -3.30% | -2.81K |
$5.43 | -$15,263.73 | 82.25K |
Sep 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
| +11.88% | 8.81K |
$11.95 | -$14,268.30 | 82.95K |
Feb 25 - Feb 26
| |||
Form 4
| -3.88% | -3.00K |
$11.43 | -$34,244.28 | 74.15K |
Feb 5
| |||
Form 4
| +1.27% | 969 |
$13.92 | -$13,279.68 | 77.14K |
Sep 28
| |||
Form 4
| -3.56% | -2.81K |
$14.00 | -$39,340.00 | 76.18K |
Sep 1
| |||
Form 4
| +9.72% | 7K |
—
|
—
| 78.99K |
Feb 26
| |||
Form 4
| -4.17% | -3.13K |
$34.34 | -$107,518.54 | 71.99K |
Mar 1
| |||
Form 4
| -20.85% | -19.78K |
$44.77 | -$885,729.68 | 75.12K |
Mar 1
| |||
Form 4
| +20.40% | 16.08K |
—
|
—
| 94.9K |
Feb 7
| |||
Form 4
|
—
|
0
|
$26.47 | -$152,166.60 | 78.82K |
Scheduled
|
Jan 18
| ||
Form 4
| -3.00% | -2.44K |
$48.60 | -$118,681.20 | 78.82K |
Jan 3
| |||
Form 4
|
—
|
0
|
$32.84 | -$93,366.00 | 81.27K |
Scheduled
|
Nov 28
| ||
Form 4
|
—
|
0
|
$33.44 | -$1,867,598.01 | 81.27K |
Scheduled
|
Nov 23 - Nov 25
| ||
Form 4
| +9.43% | 7K |
—
|
—
| 81.27K |
Sep 8
| |||
Form 4
| -20.85% | -19.57K |
$44.74 | -$875,472.32 | 74.27K |
Sep 1
| |||
Form 4
| +11.93% | 10K |
—
|
—
| 93.83K |
Aug 25
| |||
Form 4
|
—
|
0
|
$24.25 | -$315,155.50 | 83.83K |
Scheduled
|
Mar 29 - Mar 30
| ||
Form 4
|
—
|
0
|
$21.89 | -$800,224.45 | 83.57K |
Scheduled
|
Jan 27
| ||
Form 4
| +875.15% | 75K |
—
|
—
| 83.57K |
Aug 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 17
| |||
Form 4
| +248.37% | 6.11K |
—
|
—
| 8.57K |
Apr 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||